India - Ihealthfull

anti-cancer drug price control

pharma

Anti-cancer drug price control: Smart savings for consumers

Joseph Davis Nov 9, 2026 0

Anti-cancer drug price control brings significant savings for consumers, totaling Rs 3,540 crore.

Read More

pharma

NATCO Pharma Semaglutide: Clear Approval Boosts Stock by 12%

Joseph Davis Oct 3, 2026 0

NATCO Pharma Semaglutide gains 12% after CDSCO approval in India. Discover the impact on the market and future prospects.

Read More

YOU MAY HAVE MISSED

EU combination products

pharma

Are EU Combination Products the Best Solution for Approval Risks?

Joseph Davis Nov 12, 2026

anti-cancer drug price control

pharma

Anti-cancer drug price control: Smart savings for consumers

Joseph Davis Nov 9, 2026

hospital charges control

healthcare

Hospital Charges Control: Proven Ways to Save on Care

Joseph Davis Nov 4, 2026

Pharma News

Inovio stock rise: Best proven strategy for investors

Joseph Davis Nov 2, 2026